Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis

References

• MartinHLSmithLTomlinsonDCMultidrug-resistant breast cancer: current perspectivesBreast Cancer (Dove Med Press)2014611324648765
   PubMedGoogle Scholar
• TrockBJLeonessaFClarkeRMultidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significanceJ Natl Cancer Inst199789139179319214671
   PubMedGoogle Scholar
• WindNSHolenIMultidrug resistance in breast cancer: from in vitro models to clinical studiesInt J Breast Cancer2011201196741922332018
   PubMedGoogle Scholar
• BeckWTGroganTMWillmanCLMethods to detect P-glyco-protein-associated multidrug resistance in patients’ tumors: consensus recommendationsCancer Res19965613301030208674056
   PubMed Web of Science ®Google Scholar
• ClarkeRLeonessaFTrockBMultidrug resistance/P-glycoprotein and breast cancer: review and meta-analysisSemin Oncol2005326 Suppl 7S9S15
   PubMed Web of Science ®Google Scholar
• CianfrigliaMThe biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience of gemtuzumab ozogamicinAnn Ist Super Sanità201349215016823771260
   PubMed Web of Science ®Google Scholar
• Kimchi-SarfatyCOhJMKimIA “silent” polymorphism in the MDR1 gene changes substrate specificityScience2007315581152552817185560
   PubMed Web of Science ®Google Scholar
• FungKLPanJOhnumaSMDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayerCancer Res201474259860824305879
   PubMed Web of Science ®Google Scholar
• MoralesMMCapellaMAMSanchesMVLopesAGGugginoWBModulation of the mdr-1b gene in the kidney of rats subjected to dehydration or a high-salt dietPflugers Arch2000439335636210650988
   PubMed Web of Science ®Google Scholar
• IqbalMGibbWMatthewsSGCorticosteroid regulation of P-glycoprotein in the developing blood-brain barrierEndocrinology201115231067107921239442
   PubMed Web of Science ®Google Scholar
• McShaneLMAltmanDGSauerbreiWREporting recommendations for tumour MARKer prognostic studies (REMARK)Br J Cancer200593438739116106245
   PubMed Web of Science ®Google Scholar
• Vieira-Monteiro HdeAFreitas-AlvesDRSobral-LeiteMPrognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancerCancer Biol Ther201617667468327195611
   PubMed Web of Science ®Google Scholar
• DaughertySLPowersJDMagidDJIncidence and prognosis of resistant hypertension in hypertensive patientsCirculation2012125131635164222379110
   PubMed Web of Science ®Google Scholar
• EllisIOSchnittSJSastre-GarauXTumors of the breastTavassoéliFDevileePPathology and Genetics of Tumours of the Breast and Female Genital Organs3rd edLyonIARC Press20039109
   Google Scholar
• ElstonCWEllisIOPathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-upHistopathology1991194034101757079
   PubMed Web of Science ®Google Scholar
• HuoberJvon MinckwitzGDenkertCEffect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio studyBreast Cancer Res Treat2010124113314020697801
   PubMed Web of Science ®Google Scholar
• MechetnerEKyshtoobayevaAZonisSLevels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicinClin Cancer Res1998423893989516927
   PubMed Web of Science ®Google Scholar
• BoscoDBKenworthyRZorioDARSangQ-XAHuman mesenchymal stem cells are resistant to Paclitaxel by adopting a non-proliferative fibroblastic statePLoS One2015106e012851126029917
   PubMed Web of Science ®Google Scholar
• YangYQiuJ-GLiYTargeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editingAm J Transl Res2016893986399427725879
   PubMed Web of Science ®Google Scholar
• HungTHLiYHTsengCPKnockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell linesCancer Gene Ther201522526227025908454
   PubMed Web of Science ®Google Scholar
• StebbinsMJWilsonHKCanfieldSGQianTPalecekSPShustaEVDifferentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cellsMethods20161019310226518252
   PubMed Web of Science ®Google Scholar
• ThiebautFTsuruoTHamadaHGottesmanMMPastanIWillinghamMCCellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissuesProc Natl Acad Sci U S A19878421773577382444983
   PubMed Web of Science ®Google Scholar
• ThiebautFTsuruoTHamadaHGottesmanMMPastanIWillinghamMCImmunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle proteinJ Histochem Cytochem19893721591642463300
   PubMed Web of Science ®Google Scholar
• van KalkenCKvan der ValkPHadisaputroMMDifferentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidneyAnn Oncol199125562
   PubMed Web of Science ®Google Scholar
• SugawaraIKataokaIMorishitaYTissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16Cancer Res1988487192619292894894
   PubMed Web of Science ®Google Scholar
• SmitJJSchinkelAHMolCATissue distribution of the human MDR3 P-glycoproteinLab Invest19947156386497734012
   PubMed Web of Science ®Google Scholar
• SchefferGLKoolMHeijnMSpecific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodiesCancer Res200060185269527711016657
   PubMed Web of Science ®Google Scholar
• KirkegaardTEdwardsJToveySObserver variation in immunohistochemical analysis of protein expression, time for a change?Histopathology200648778779416722926
   PubMed Web of Science ®Google Scholar
• SurowiakPMaternaVMatkowskiRRelationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significanceBreast Cancer Res200575R862R87016168133
   PubMed Web of Science ®Google Scholar
• GoswamiCPNakshatriHPROGgeneV2: enhancements on the existing databaseBMC Cancer20141497025518851
   PubMed Web of Science ®Google Scholar
• SzászAMLánczkyANagyÁCross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patientsOncotarget2016731493224933327384994
   PubMedGoogle Scholar
• Monteiro HdeAVGoulart-CitranguloSMTLeiteMSGiacominLCVianna-JorgeRInfluência de Variáveis Clinicopatológicas sobre a Eficácia da Quimioterapia Neoadjuvante do Câncer de Mama [Influence of Clinicopathological Variables on the Efficacy of Neoadjuvant]Rev Bras Cancerol2013593369377 Portuguese
   Google Scholar
• Vieira-Monteiro HdeAFreitas-AlvesDRSobral-LeiteMPrognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancerCancer Biol Ther201617667468327195611
   PubMed Web of Science ®Google Scholar
• SkalandINordhusMGudlaugssonEEvaluation of 5 different labeled polymer immunohistochemical detection systemsAppl Immunohistochem Mol Morphol2010181909619661787
   PubMedGoogle Scholar
• CharpinCVielhPDuffaudFQuantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicatorsJ Natl Cancer Inst19948620153915457932810
   PubMedGoogle Scholar
• LinnSCGiacconeGvan DiestPJPrognostic relevance of P-glycoprotein expression in breast cancerAnn Oncol1995676796858664189
   PubMed Web of Science ®Google Scholar
• SeymourLBezwodaWRDanseyRDP-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancerBreast Cancer Res Treat199536161697579508
   PubMed Web of Science ®Google Scholar
• CharpinCBouvierCGarciaSAutomated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomasInt J Cancer19977444164209291431
   PubMed Web of Science ®Google Scholar
• CharpinCGarciaSBouvierCAutomated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomasBr J Cancer19977633403469252201
   PubMed Web of Science ®Google Scholar
• LarkinAO’DriscollLKennedySInvestigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic studyInt J Cancer2004112228629415352042
   PubMed Web of Science ®Google Scholar
• KurodaHIshidaFNakaiMOhnisiKItoyamaSBasal cytokeratin expression in relation to biological factors in breast cancerHum Pathol200839121744175018755493
   PubMed Web of Science ®Google Scholar
• PavelicZPSeverZFontaineRNDetection of P-glycoprotein with JSB-1 monoclonal antibody in B-5 fixed and paraffin-embedded cell lines and tissuesSel Cancer Ther19917249581721722
   PubMedGoogle Scholar
• ScalaSSaekiTLynchASalomonDMerinoMJBatesSECoexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissuesDiagn Mol Pathol1995421361427551294
   PubMedGoogle Scholar
• ZhuZWangBBiJCytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancerTumour Biol20133442299230823605320
   PubMedGoogle Scholar
• DoxaniCVoulgarelisMZintzarasEMDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysisBiomarkers201318542543523805980
   PubMed Web of Science ®Google Scholar
• SauerGKafkaAGrundmannRKreienbergRZeillingerRDeisslerHBasal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell linesCancer Lett20021851798512142082
   PubMed Web of Science ®Google Scholar
• TaheriMMahjoubiFOmranipourREffect of MDR1 polymorphism on multidrug resistance expression in breast cancer patientsGenet Mol Res201091344020082268
   PubMed Web of Science ®Google Scholar
• Lopes-RodriguesVSecaHSousaDSousaELimaRTVasconcelosMHThe network of P-glycoprotein and microRNAs interactionsInt J Cancer2014135225326324122334
   PubMed Web of Science ®Google Scholar
• De La TorreMLarssonRNygrenPLindgrenABerghJExpression of the multidrug-resistance gene product in untreated human breast cancer and its relationship to prognostic markersActa Oncol19943377737777993645
   PubMed Web of Science ®Google Scholar
• LuLSChenLDingWXLiKWuJJElevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancerEur Rev Med Pharmacol Sci201216152037204323280016
   PubMed Web of Science ®Google Scholar
• ValenteRCCapellaLSNascimentoCRABCB1 (P-glycoprotein) but not ABCC1 (MRP1) is downregulated in peripheral blood mononuclear cells of spontaneously hypertensive ratsPflugers Arch2008456235936818057958
   PubMed Web of Science ®Google Scholar
• KangHJSongISLeeSSYooMAShinJGEffects of dietary salt on the expression of drug transporters, cytochrome P4503a, and nuclear receptors in ratsXenobiotica20083814715518197556
   PubMed Web of Science ®Google Scholar
• SasanoHFrostARSaitohRLocalization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disordersAnticancer Res1997173C200120079216657
   PubMed Web of Science ®Google Scholar
• TahmasebiMBarkerSPuddefootJRVinsonGPLocalisation of renin-angiotensin system (RAS) components in breastBr J Cancer2006951677416755291
   PubMed Web of Science ®Google Scholar
• MizutaniTMasudaMNakaiEGenuine functions of P-glycoprotein (ABCB1)Curr Drug Metab20089216717418288958
   PubMed Web of Science ®Google Scholar
• LeidyJKhanAKandilDBasal-like breast cancer: update on clinicopathologic, immunohistochemical, and molecular featuresArch Pathol Lab Med20141381374324377810
   PubMed Web of Science ®Google Scholar
• van de VijverMJHeYDvan’t VeerLJA gene-expression signature as a predictor of survival in breast cancerN Engl J Med2002347251999200912490681
   PubMed Web of Science ®Google Scholar
• SchmidtMBöhmDvon TörneCThe humoral immune system has a key prognostic impact in node-negative breast cancerCancer Res200868135405541318593943
   PubMed Web of Science ®Google Scholar
• IvshinaAVGeorgeJSenkoOGenetic reclassification of histologic grade delineates new clinical subtypes of breast cancerCancer Res20066621102921030117079448
   PubMed Web of Science ®Google Scholar
• BuffaFMCampsCWinchesterLmicroRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancerCancer Res201171175635564521737487
   PubMed Web of Science ®Google Scholar
• SymmansWFHatzisCSotiriouCGenomic index of sensitivity to endocrine therapy for breast cancerJ Clin Oncol201028274111411920697068
   PubMed Web of Science ®Google Scholar
• WangYKlijnJGMZhangYGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerLancet2005365946067167915721472
   PubMed Web of Science ®Google Scholar
• MillerLDSmedsJGeorgeJAn expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProc Natl Acad Sci U S A200510238135501355516141321
   PubMed Web of Science ®Google Scholar
• SabatierRFinettiPCerveraNA gene expression signature identifies two prognostic subgroups of basal breast cancerBreast Cancer Res Treat2011126240742020490655
   PubMed Web of Science ®Google Scholar
• Center for Computational Biology and Bioinformatics, Indiana University–Purdue University IndianapolisPROGgeneV2 - Pan Cancer Prognostics Database Available from: http://watson.compbio.iupui.edu/chirayu/proggene/database/?url=proggeneAccessed May 15, 2017
   Google Scholar